Evaluation of incipient cavitation erosion for pipe wall at downstream of an orifice

Cavitation induced vibration and the consequent erosion of pipes are the potential damaging factors in the piping systems. In order to prevent such trouble, it is preferable to develop a detection method for cavitation occurrence. Especially, in power plants, it is necessary to detect cavitation from the outside of the piping during operation. In this paper, in order to evaluate incipience of cavitation erosion, we carried out cavitation erosion experiments using aluminium specimens and we measured impulsive force induced by cavitation bubbles collapse using impact force detectors. In the cavitation erosion experiments, the incipient cavitation numbers, where cavitation erosion pits occured, were 0.8 at 50mm and 75mm downstream from the orifice and 0.7 at 100mm downstream. At those cavitation numbers, the states of cavitation was in a developed state or nearly so. In the measurements of impulsive force, the cavitation number, where impulsive force began to increase, was almost with the same as cavitation numbers at the occurrence of erosion pits.http://deepblue.lib.umich.edu/bitstream/2027.42/84261/1/CAV2009-final64.pd

Linear response strength functions with iterative Arnoldi diagonalization

We report on an implementation of a new method to calculate RPA strength functions with iterative non-hermitian Arnoldi diagonalization method, which does not explicitly calculate and store the RPA matrix. We discuss the treatment of spurious modes, numerical stability, and how the method scales as the used model space is enlarged. We perform the particle-hole RPA benchmark calculations for double magic nucleus 132Sn and compare the resulting electromagnetic strength functions against those obtained within the standard RPA.Comment: 9 RevTeX pages, 11 figures, submitted to Physical Review

Di-neutron correlation and soft dipole excitation in medium mass neutron-rich nuclei near drip-line

The neutron pairing correlation and the soft dipole excitation in medium-mass nuclei near drip-line are investigated from a viewpoint of the di-neutron correlation. Numerical analyses by means of the coordinate-space HFB and the continuum QRPA methods are performed for even-even $^{18-24}$O, $^{50-58}$Ca and $^{80-86}$Ni. A clear signature of the di-neutron correlation is found in the HFB ground state; two neutrons are correlated at short relative distances \lesim 2 fm with large probability $\sim 50$. The soft dipole excitation is influenced strongly by the neutron pairing correlation, and it accompanies a large transition density for pair motion of neutrons. This behavior originates from a coherent superposition of two-quasiparticle configurations $[l\times (l+1)]_{L=1}$ consisting of continuum states with high orbital angular momenta $l$ reaching an order of $l\sim 10$. It raises a picture that the soft dipole excitation under the influence of neutron pairing is characterized by motion of di-neutron in the nuclear exterior against the remaining $A-2$ subsystem. Sensitivity to the density dependence of effective pair force is discussed.Comment: 35 pages, 22 figure

Instabilities in the Nuclear Energy Density Functional

In the field of Energy Density Functionals (EDF) used in nuclear structure and dynamics, one of the unsolved issues is the stability of the functional. Numerical issues aside, some EDFs are unstable with respect to particular perturbations of the nuclear ground-state density. The aim of this contribution is to raise questions about the origin and nature of these instabilities, the techniques used to diagnose and prevent them, and the domain of density functions in which one should expect a nuclear EDF to be stable.Comment: Special issue "Open Problems in Nuclear Structure Theory" of Jour.Phys.G - accepted. 7 pages, 2 figure

Error analysis of nuclear mass fits

We discuss the least-square and linear-regression methods, which are relevant for a reliable determination of good nuclear-mass-model parameter sets and their errors. In this perspective, we define exact and inaccurate models and point out differences in using the standard error analyses for them. As an illustration, we use simple analytic models for nuclear binding energies and study the validity and errors of models' parameters, and uncertainties of its mass predictions. In particular, we show explicitly the influence of mass-number dependent weights on uncertainties of liquid-drop global parameters.Comment: 10 RevTeX pages, 9 figures, submitted to Physical Review

Research and development for accuracy improvement of neutron nuclear data on minor actinides

To improve accuracy of neutron nuclear data on minor actinides, a Japanese nuclear data project entitled “Research and development for Accuracy Improvement of neutron nuclear data on Minor ACtinides (AIMAC)” has been implemented. Several independent measurement techniques were developed for improving measurement precision at J-PARC/MLF/ANNRI and KURRI/LINAC facilities. Effectiveness of combining the independent techniques has been demonstrated for identifying bias effects and improving accuracy, especially in characterization of samples used for nuclear data measurements. Capture cross sections and/or total cross sections have been measured for Am-241, Am-243, Np-237, Tc-99, Gd-155, and Gd-157. Systematic nuclear data evaluation has also been performed by taking into account the identified bias effect. Highlights of the AIMAC project are outlined

Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections

Lumbar interlaminar and transforaminal epidural injections are used in the treatment of lumbar radicular pain and other lumbar spinal pain syndromes. Complications from these procedures arise from needle placement and the administration of medication. Potential risks include infection, hematoma, intravascular injection of medication, direct nerve trauma, subdural injection of medication, air embolism, disc entry, urinary retention, radiation exposure, and hypersensitivity reactions. The objective of this article is to review the complications of lumbar interlaminar and transforaminal epidural injections and discuss the potential pitfalls related to these procedures. We performed a comprehensive literature review through a Medline search for relevant case reports, clinical trials, and review articles. Complications from lumbar epidural injections are extremely rare. Most if not all complications can be avoided by careful technique with accurate needle placement, sterile precautions, and a thorough understanding of the relevant anatomy and contrast patterns on fluoroscopic imaging

Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

BACKGROUND AND PURPOSE: Chronic kidney disease with reduced estimated glomerular filtration rate or elevated albuminuria increases risk for ischemic and hemorrhagic stroke. This study assessed the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on stroke and atrial fibrillation/flutter (AF/AFL) from CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) and a meta-Analysis of large cardiovascular outcome trials (CVOTs) of SGLT2i in type 2 diabetes mellitus. METHODS: CREDENCE randomized 4401 participants with type 2 diabetes mellitus and chronic kidney disease to canagliflozin or placebo. Post hoc, we estimated effects on fatal or nonfatal stroke, stroke subtypes, and intermediate markers of stroke risk including AF/AFL. Stroke and AF/AFL data from 3 other completed large CVOTs and CREDENCE were pooled using random-effects meta-Analysis. RESULTS: In CREDENCE, 142 participants experienced a stroke during follow-up (10.9/1000 patient-years with canagliflozin, 14.2/1000 patient-years with placebo; hazard ratio [HR], 0.77 [95% CI, 0.55-1.08]). Effects by stroke subtypes were: ischemic (HR, 0.88 [95% CI, 0.61-1.28]; n=111), hemorrhagic (HR, 0.50 [95% CI, 0.19-1.32]; n=18), and undetermined (HR, 0.54 [95% CI, 0.20-1.46]; n=17). There was no clear effect on AF/AFL (HR, 0.76 [95% CI, 0.53-1.10]; n=115). The overall effects in the 4 CVOTs combined were: Total stroke (HRpooled, 0.96 [95% CI, 0.82-1.12]), ischemic stroke (HRpooled, 1.01 [95% CI, 0.89-1.14]), hemorrhagic stroke (HRpooled, 0.50 [95% CI, 0.30-0.83]), undetermined stroke (HRpooled, 0.86 [95% CI, 0.49-1.51]), and AF/AFL (HRpooled, 0.81 [95% CI, 0.71-0.93]). There was evidence that SGLT2i effects on total stroke varied by baseline estimated glomerular filtration rate (P=0.01), with protection in the lowest estimated glomerular filtration rate (45 mL/min/1.73 m2]) subgroup (HRpooled, 0.50 [95% CI, 0.31-0.79]). CONCLUSIONS: Although we found no clear effect of SGLT2i on total stroke in CREDENCE or across trials combined, there was some evidence of benefit in preventing hemorrhagic stroke and AF/AFL, as well as total stroke for those with lowest estimated glomerular filtration rate. Future research should focus on confirming these data and exploring potential mechanisms

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to 300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m 2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years